NEOPLASMS BY SITE

This program provides access to the experimental drug taletrectinib for adults with advanced ROS1-positive lung cancer who have run out of approved treatment options and cannot join regular clinical trials. The drug aims to control cancer growth in patients who have already tried…

This is a first-in-human study to find a safe dose and see how the body processes a new oral drug called ATV-1601. It is being tested in adults with advanced solid tumors, including certain breast cancers, that have a specific genetic change called an AKT1 E17K mutation. The main…

This study is observing how well a combination of the drug Osimertinib and standard chemotherapy works for people with a specific type of advanced lung cancer (EGFR-positive NSCLC) in a real-world setting. It involves 532 adult patients who have already started this specific trea…

This study is testing a new targeted drug called savolitinib for people with an advanced form of kidney cancer called MET-driven papillary renal cell carcinoma (PRCC). It compares savolitinib directly against sunitinib, a standard treatment, to see which is better at controlling …

This study compares two standard treatments for early-stage throat cancer to see which better preserves patients' quality of life, especially their ability to swallow. It randomly assigns 138 patients to receive either minimally invasive robotic surgery or targeted radiation ther…

This study aims to see if providing standardized training to cancer doctors in smaller city and county hospitals leads to better testing and treatment for patients with advanced non-small cell lung cancer. It will follow 1,000 patients to measure if doctors order more recommended…